143 related articles for article (PubMed ID: 30023837)
1. Cardinal Role of Intraliposome Doxorubicin-Sulfate Nanorod Crystal in Doxil Properties and Performance.
Wei X; Shamrakov D; Nudelman S; Peretz-Damari S; Nativ-Roth E; Regev O; Barenholz Y
ACS Omega; 2018 Mar; 3(3):2508-2517. PubMed ID: 30023837
[TBL] [Abstract][Full Text] [Related]
2. Effect of the ammonium salt anion on the structure of doxorubicin complex and PEGylated liposomal doxorubicin nanodrugs.
Schilt Y; Berman T; Wei X; Nativ-Roth E; Barenholz Y; Raviv U
Biochim Biophys Acta Gen Subj; 2021 May; 1865(5):129849. PubMed ID: 33460771
[TBL] [Abstract][Full Text] [Related]
3. Insights into composition/structure/function relationships of Doxil® gained from "high-sensitivity" differential scanning calorimetry.
Wei X; Cohen R; Barenholz Y
Eur J Pharm Biopharm; 2016 Jul; 104():260-70. PubMed ID: 27106607
[TBL] [Abstract][Full Text] [Related]
4. Using solution X-ray scattering to determine the high-resolution structure and morphology of PEGylated liposomal doxorubicin nanodrugs.
Schilt Y; Berman T; Wei X; Barenholz Y; Raviv U
Biochim Biophys Acta; 2016 Jan; 1860(1 Pt A):108-19. PubMed ID: 26391840
[TBL] [Abstract][Full Text] [Related]
5. The antioxidant tempamine: in vitro antitumor and neuroprotective effects and optimization of liposomal encapsulation and release.
Wasserman V; Kizelsztein P; Garbuzenko O; Kohen R; Ovadia H; Tabakman R; Barenholz Y
Langmuir; 2007 Feb; 23(4):1937-47. PubMed ID: 17279678
[TBL] [Abstract][Full Text] [Related]
6. Transmembrane ammonium sulfate gradients in liposomes produce efficient and stable entrapment of amphipathic weak bases.
Haran G; Cohen R; Bar LK; Barenholz Y
Biochim Biophys Acta; 1993 Sep; 1151(2):201-15. PubMed ID: 8373796
[TBL] [Abstract][Full Text] [Related]
7. Remote loading of doxorubicin into liposomes driven by a transmembrane phosphate gradient.
Fritze A; Hens F; Kimpfler A; Schubert R; Peschka-Süss R
Biochim Biophys Acta; 2006 Oct; 1758(10):1633-40. PubMed ID: 16887094
[TBL] [Abstract][Full Text] [Related]
8. Folded, undulating, and fibrous doxorubicin sulfate crystals in liposomes.
Yamamoto E; Hosogi N; Takechi-Haraya Y; Izutsu KI; Uchiyama N; Goda Y
Nanomedicine; 2023 Jan; 47():102631. PubMed ID: 36410700
[TBL] [Abstract][Full Text] [Related]
9. Doxebo (doxorubicin-free Doxil-like liposomes) is safe to use as a pre-treatment to prevent infusion reactions to PEGylated nanodrugs.
Bavli Y; Winkler I; Chen BM; Roffler S; Cohen R; Szebeni J; Barenholz Y
J Control Release; 2019 Jul; 306():138-148. PubMed ID: 31176656
[TBL] [Abstract][Full Text] [Related]
10. Investigation of factors affecting in vitro doxorubicin release from PEGylated liposomal doxorubicin for the development of in vitro release testing conditions.
Shibata H; Izutsu K; Yomota C; Okuda H; Goda Y
Drug Dev Ind Pharm; 2015; 41(8):1376-86. PubMed ID: 25170659
[TBL] [Abstract][Full Text] [Related]
11. Small-Angle X-ray Scattering for PEGylated Liposomal Doxorubicin Drugs: An Analytical Model Comparison Study.
Li Y; Zhang J; Song P; Miao X; Liu G; Yang C; Wei X; Li N; Bian F
Mol Pharm; 2023 Sep; 20(9):4654-4663. PubMed ID: 37616278
[TBL] [Abstract][Full Text] [Related]
12. Encapsulation of doxorubicin into thermosensitive liposomes via complexation with the transition metal manganese.
Chiu GN; Abraham SA; Ickenstein LM; Ng R; Karlsson G; Edwards K; Wasan EK; Bally MB
J Control Release; 2005 May; 104(2):271-88. PubMed ID: 15907579
[TBL] [Abstract][Full Text] [Related]
13. Copper ion-mediated liposomal encapsulation of mitoxantrone: the role of anions in drug loading, retention and release.
Li C; Cui J; Li Y; Wang C; Li Y; Zhang L; Zhang L; Guo W; Wang J; Zhang H; Hao Y; Wang Y
Eur J Pharm Sci; 2008 Aug; 34(4-5):333-44. PubMed ID: 18573336
[TBL] [Abstract][Full Text] [Related]
14. Heating treatments affect the thermal behaviour of doxorubicin loaded in PEGylated liposomes.
Perinelli DR; Cespi M; Bonacucina G; Rendina F; Palmieri GF
Int J Pharm; 2017 Dec; 534(1-2):81-88. PubMed ID: 28993166
[TBL] [Abstract][Full Text] [Related]
15. The effects of pH and intraliposomal buffer strength on the rate of liposome content release and intracellular drug delivery.
Lee RJ; Wang S; Turk MJ; Low PS
Biosci Rep; 1998 Apr; 18(2):69-78. PubMed ID: 9743475
[TBL] [Abstract][Full Text] [Related]
16. Determination of key parameters for a mechanism-based model to predict Doxorubicin release from actively loaded liposomes.
Csuhai E; Kangarlou S; Xiang TX; Ponta A; Bummer P; Choi D; Anderson BD
J Pharm Sci; 2015 Mar; 104(3):1087-98. PubMed ID: 25561354
[TBL] [Abstract][Full Text] [Related]
17. Reduced UV-induced degradation of doxorubicin encapsulated in polyethyleneglycol-coated liposomes.
Bandak S; Ramu A; Barenholz Y; Gabizon A
Pharm Res; 1999 Jun; 16(6):841-6. PubMed ID: 10397603
[TBL] [Abstract][Full Text] [Related]
18. Influence of ammonium nitrate on the crystallisation of ammonium sulfate.
Huang B; Dai M; Wen Z; Li W; Zi G; Luo L; Shi Z; Yang L
Environ Technol; 2024 Apr; 45(11):2196-2204. PubMed ID: 36606665
[TBL] [Abstract][Full Text] [Related]
19. Doxil®--the first FDA-approved nano-drug: lessons learned.
Barenholz Y
J Control Release; 2012 Jun; 160(2):117-34. PubMed ID: 22484195
[TBL] [Abstract][Full Text] [Related]
20. Quantitative Cryo-TEM Reveals New Structural Details of Doxil-Like PEGylated Liposomal Doxorubicin Formulation.
Nordström R; Zhu L; Härmark J; Levi-Kalisman Y; Koren E; Barenholz Y; Levinton G; Shamrakov D
Pharmaceutics; 2021 Jan; 13(1):. PubMed ID: 33478023
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
